Sucampo Pharmaceuticals, Inc. (Nasdaq: SCMP) and Abbott (NYSE: ABT) announced the availability of AMITIZA (lubiprostone) in Japan, a prescription medicine ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE